Immuno-Radiotherapy Enhances Tumor Control and Induces Abscopal Responses in a Humanized Mouse Model

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated deep summary by claude@2026-07, 2026-07-04 · read from full text

This preprint studied how radiation therapy (RT) dose-fractionation regimens modulate local and systemic antitumor immunity when combined with immune checkpoint inhibitors (ICIs) in a hematopoietic stem cell-humanized NOG mouse model bearing ICI-responsive renal cell carcinoma (RCC), ICI-resistant non-small cell lung cancer (NSCLC), and melanoma. The authors found that immuno-RT (iRT) improved tumor control across models and induced abscopal effects in ICI-resistant settings, with the strongest systemic responses in NSCLC after 3×8 Gy plus ICI, including increased circulating monocytes and remodeling of the tumor microenvironment; late-stage resistant tumors showed low immune infiltration alongside high immune memory, activation of the cGAS/STING pathway, increased damage-associated molecular patterns, cell death, and metabolic reprogramming, assessed by flow cytometry, immunohistochemistry, and RNA-sequencing. A key limitation explicitly acknowledged is that the work is a non-peer-reviewed preprint. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Radiation therapy (RT) offers a tool to enhance immune checkpoint inhibitor (ICI) efficacy, yet its immunomodulatory potential remains poorly understood. Using a hematopoietic stem cell-humanized NOG mouse model bearing ICI-responsive renal cell carcinoma (RCC) or ICI-resistant non-small cell lung cancer (NSCLC) and melanoma, we reveal how RT dose-fractionation regimens shape local and systemic antitumor immunity. Immuno-RT (iRT) improved tumor control across models, and induced abscopal effects in ICI-resistant models, especially in NSCLC, where 3x8 Gy combined with ICI triggered systemic responses, increased circulating monocytes and remodeled the tumor microenvironment (TME). Flow cytometry, immunohistochemistry, and RNA-sequencing revealed dynamic immune remodeling, with late-stage responses in ICI-resistant tumors marked by low immune infiltration, high immune memory, cGAS/STING pathway, damage associated molecular patterns, cell death, and metabolic reprograming. Our findings support RT as a strategy to overcome ICI resistance and validate humanized mice as a translational model for iRT research.
Full text 13,932 characters · extracted from preprint-html · click to expand
Immuno-Radiotherapy Enhances Tumor Control and Induces Abscopal Responses in a Humanized Mouse Model | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Immuno-Radiotherapy Enhances Tumor Control and Induces Abscopal Responses in a Humanized Mouse Model Sébastien Penninckx, Morgane Cogels, Matteo Serra, Hugues Duvillier, and 11 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7188100/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Radiation therapy (RT) offers a tool to enhance immune checkpoint inhibitor (ICI) efficacy, yet its immunomodulatory potential remains poorly understood. Using a hematopoietic stem cell-humanized NOG mouse model bearing ICI-responsive renal cell carcinoma (RCC) or ICI-resistant non-small cell lung cancer (NSCLC) and melanoma, we reveal how RT dose-fractionation regimens shape local and systemic antitumor immunity. Immuno-RT (iRT) improved tumor control across models, and induced abscopal effects in ICI-resistant models, especially in NSCLC, where 3x8 Gy combined with ICI triggered systemic responses, increased circulating monocytes and remodeled the tumor microenvironment (TME). Flow cytometry, immunohistochemistry, and RNA-sequencing revealed dynamic immune remodeling, with late-stage responses in ICI-resistant tumors marked by low immune infiltration, high immune memory, cGAS/STING pathway, damage associated molecular patterns, cell death, and metabolic reprograming. Our findings support RT as a strategy to overcome ICI resistance and validate humanized mice as a translational model for iRT research. Biological sciences/Cancer/Cancer therapy/Radiotherapy Biological sciences/Cancer/Cancer therapy/Cancer immunotherapy Full Text Additional Declarations There is NO Competing Interest. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7188100","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":491927984,"identity":"69ef2ff3-9dfc-4803-af73-6b9cb4197f98","order_by":0,"name":"Sébastien Penninckx","email":"data:image/png;base64,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","orcid":"https://orcid.org/0000-0002-3016-778X","institution":"Institut Jules Bordet","correspondingAuthor":true,"prefix":"","firstName":"Sébastien","middleName":"","lastName":"Penninckx","suffix":""},{"id":491927985,"identity":"e331e85b-ba9b-48f4-9961-b27e3fc1ef75","order_by":1,"name":"Morgane Cogels","email":"","orcid":"","institution":"","correspondingAuthor":false,"prefix":"","firstName":"Morgane","middleName":"","lastName":"Cogels","suffix":""},{"id":491927986,"identity":"d7575592-7b28-4d33-a06e-76a3409ddb4e","order_by":2,"name":"Matteo Serra","email":"","orcid":"","institution":"Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université libre de Bruxelles (ULB)","correspondingAuthor":false,"prefix":"","firstName":"Matteo","middleName":"","lastName":"Serra","suffix":""},{"id":491927987,"identity":"9ab6adb9-4996-4256-9095-4de2525e6fa5","order_by":3,"name":"Hugues Duvillier","email":"","orcid":"","institution":"Université Libre de Bruxelles","correspondingAuthor":false,"prefix":"","firstName":"Hugues","middleName":"","lastName":"Duvillier","suffix":""},{"id":491927988,"identity":"6672ccaf-b276-402c-85e0-5c8e80c1918d","order_by":4,"name":"Soizic Garaud","email":"","orcid":"","institution":"Université Libre de Bruxelles","correspondingAuthor":false,"prefix":"","firstName":"Soizic","middleName":"","lastName":"Garaud","suffix":""},{"id":491927989,"identity":"8b0cb66f-5c29-4ebb-ba39-34b659509603","order_by":5,"name":"Laurine Verset","email":"","orcid":"","institution":"Jules Bordet Institute HUB","correspondingAuthor":false,"prefix":"","firstName":"Laurine","middleName":"","lastName":"Verset","suffix":""},{"id":491927990,"identity":"eee8ab6a-a9c5-4057-8af9-76c22e829200","order_by":6,"name":"David Venet","email":"","orcid":"","institution":"Institut Jules Bordet, Hôpital Universitaire de Bruxelles","correspondingAuthor":false,"prefix":"","firstName":"David","middleName":"","lastName":"Venet","suffix":""},{"id":491927991,"identity":"9672bbad-f5c6-4924-b2f2-647bc824b80b","order_by":7,"name":"Chrysanthi Iliadi","email":"","orcid":"","institution":"institut Jules Bordet","correspondingAuthor":false,"prefix":"","firstName":"Chrysanthi","middleName":"","lastName":"Iliadi","suffix":""},{"id":491927992,"identity":"facc4236-3a09-4f96-946e-4d1df09df515","order_by":8,"name":"Tycho de Bakker","email":"","orcid":"","institution":"Institut Jules Bordet","correspondingAuthor":false,"prefix":"","firstName":"Tycho","middleName":"","lastName":"de Bakker","suffix":""},{"id":491927993,"identity":"f2dac68b-9143-422d-a456-a9172b91d324","order_by":9,"name":"Laurence Buisseret","email":"","orcid":"https://orcid.org/0000-0002-3751-0819","institution":"Institut Jules Bordet","correspondingAuthor":false,"prefix":"","firstName":"Laurence","middleName":"","lastName":"Buisseret","suffix":""},{"id":491927994,"identity":"b1c25e72-2ef1-4780-92c1-5f5342ae3410","order_by":10,"name":"Redouane Rouas","email":"","orcid":"","institution":"Institut Jules Bordet","correspondingAuthor":false,"prefix":"","firstName":"Redouane","middleName":"","lastName":"Rouas","suffix":""},{"id":491927995,"identity":"526fb27a-30fa-4ea7-936c-127d75f8c1a0","order_by":11,"name":"Christos Sotiriou","email":"","orcid":"https://orcid.org/0000-0002-5745-9977","institution":"Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université libre de Bruxelles (ULB)","correspondingAuthor":false,"prefix":"","firstName":"Christos","middleName":"","lastName":"Sotiriou","suffix":""},{"id":491927996,"identity":"54ba4668-7c37-45fd-bd6a-b8a71a495ea3","order_by":12,"name":"Francoise Rothe","email":"","orcid":"","institution":"Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université libre de Bruxelles (ULB)","correspondingAuthor":false,"prefix":"","firstName":"Francoise","middleName":"","lastName":"Rothe","suffix":""},{"id":491927997,"identity":"6be78b3e-6834-4467-8cea-463cec0a08b7","order_by":13,"name":"Alex De Caluwé","email":"","orcid":"https://orcid.org/0000-0001-5989-7017","institution":"Institut Jules Bordet","correspondingAuthor":false,"prefix":"","firstName":"Alex","middleName":"","lastName":"De Caluwé","suffix":""},{"id":491927998,"identity":"d2623989-7aa2-4fe1-b4fa-7ab41f4a5e44","order_by":14,"name":"Dirk Van Gestel","email":"","orcid":"","institution":"Institut Jules Bordet","correspondingAuthor":false,"prefix":"","firstName":"Dirk","middleName":"Van","lastName":"Gestel","suffix":""}],"badges":[],"createdAt":"2025-07-22 14:25:13","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7188100/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7188100/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":90611149,"identity":"3f0ed5e2-f4dd-4b2f-b085-ee1b36c8e663","added_by":"auto","created_at":"2025-09-04 17:00:53","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":11382882,"visible":true,"origin":"","legend":"Article File","description":"","filename":"250722ResearchPaperCogels.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7188100/v1_covered_9ae1d8f7-bd6d-4e97-8f49-882a687fc863.pdf"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"Immuno-Radiotherapy Enhances Tumor Control and Induces Abscopal Responses in a Humanized Mouse Model","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-7188100/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7188100/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"Radiation therapy (RT) offers a tool to enhance immune checkpoint inhibitor (ICI) efficacy, yet its immunomodulatory potential remains poorly understood. Using a hematopoietic stem cell-humanized NOG mouse model bearing ICI-responsive renal cell carcinoma (RCC) or ICI-resistant non-small cell lung cancer (NSCLC) and melanoma, we reveal how RT dose-fractionation regimens shape local and systemic antitumor immunity. Immuno-RT (iRT) improved tumor control across models, and induced abscopal effects in ICI-resistant models, especially in NSCLC, where 3x8 Gy combined with ICI triggered systemic responses, increased circulating monocytes and remodeled the tumor microenvironment (TME). Flow cytometry, immunohistochemistry, and RNA-sequencing revealed dynamic immune remodeling, with late-stage responses in ICI-resistant tumors marked by low immune infiltration, high immune memory, cGAS/STING pathway, damage associated molecular patterns, cell death, and metabolic reprograming. Our findings support RT as a strategy to overcome ICI resistance and validate humanized mice as a translational model for iRT research.","manuscriptTitle":"Immuno-Radiotherapy Enhances Tumor Control and Induces Abscopal Responses in a Humanized Mouse Model","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-07-29 05:31:38","doi":"10.21203/rs.3.rs-7188100/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"b43aa341-4470-407a-b219-2a335fd1a36e","owner":[],"postedDate":"July 29th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":52225886,"name":"Biological sciences/Cancer/Cancer therapy/Radiotherapy"},{"id":52225887,"name":"Biological sciences/Cancer/Cancer therapy/Cancer immunotherapy"}],"tags":[],"updatedAt":"2025-09-04T16:52:33+00:00","versionOfRecord":[],"versionCreatedAt":"2025-07-29 05:31:38","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-7188100","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7188100","identity":"rs-7188100","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-4.0